FERTIN PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 25834844
Dandyvej 19, 7100 Vejle
Income statement (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 882.00 | 991.00 | 933.00 | 892.58 | 1 012.57 |
| Costs of manufacturing | - 867.42 | - 978.42 | |||
| Gross profit | 882.00 | 991.00 | 933.00 | 25.16 | 34.14 |
| Costs of management | -60.46 | -66.60 | |||
| Costs of distribution | -39.52 | -43.45 | |||
| Total depreciation | - 129.01 | - 120.94 | |||
| EBIT | 138.00 | 192.00 | 96.00 | -74.81 | -75.90 |
| Other financial income | 0.13 | 4.00 | |||
| Other financial expenses | -14.08 | -54.00 | |||
| Net income from associates (fin.) | -24.83 | -37.07 | |||
| Pre-tax profit | 81.00 | 155.00 | 38.00 | - 113.59 | - 162.97 |
| Income taxes | 22.21 | 26.27 | |||
| Net earnings | 81.00 | 155.00 | 38.00 | -91.38 | - 136.70 |
Assets (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 343.00 | 407.36 | |||
| Goodwill | 78.82 | 73.89 | |||
| Intangible assets total | 421.82 | 481.25 | |||
| Land and waters | 486.19 | 456.63 | |||
| Buildings | 445.33 | 418.68 | |||
| Machinery and equipment | 4.68 | 4.44 | |||
| Advance payments and construction in progress | 240.27 | 313.50 | |||
| Tangible assets total | 1 176.47 | 1 193.25 | |||
| Holdings in group member companies | 65.75 | 67.66 | |||
| Investments total | 1 894.00 | 1 998.00 | 2 021.00 | 65.75 | 67.66 |
| Long term receivables total | |||||
| Semifinished products | 30.00 | 31.36 | |||
| Raw materials and consumables | 144.68 | 145.58 | |||
| Finished products/goods | 43.92 | 96.31 | |||
| Inventories total | 218.60 | 273.25 | |||
| Current trade debtors | 156.79 | 149.43 | |||
| Current amounts owed by group member comp. | 177.22 | 315.00 | |||
| Prepayments and accrued income | 6.07 | 10.20 | |||
| Current other receivables | 0.35 | 2.35 | |||
| Short term receivables total | 340.44 | 476.97 | |||
| Cash and bank deposits | 26.40 | 5.82 | |||
| Cash and cash equivalents | 26.40 | 5.82 | |||
| Balance sheet total (assets) | 1 894.00 | 1 998.00 | 2 021.00 | 2 249.47 | 2 498.20 |
Equity and liabilities (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 778.00 | 770.00 | 681.00 | 70.51 | 70.51 |
| Other reserves | 277.45 | 326.49 | |||
| Retained earnings | -81.00 | - 155.00 | -38.00 | 339.76 | 198.11 |
| Profit of the financial year | 81.00 | 155.00 | 38.00 | -91.38 | - 136.70 |
| Shareholders equity total | 778.00 | 770.00 | 681.00 | 596.35 | 458.41 |
| Provisions | 139.98 | 125.78 | |||
| Non-current owed to group member | 1 564.54 | ||||
| Non-current deferred tax liabilities | 36.90 | 37.69 | |||
| Non-current liabilities total | 36.90 | 1 602.23 | |||
| Current loans from credit institutions | 0.44 | 0.70 | |||
| Current trade creditors | 84.88 | 101.69 | |||
| Current owed to group member | 1 237.23 | 36.25 | |||
| Other non-interest bearing current liabilities | 153.69 | 173.15 | |||
| Current liabilities total | 1 476.25 | 311.79 | |||
| Balance sheet total (liabilities) | 778.00 | 770.00 | 681.00 | 2 249.47 | 2 498.20 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.